Hoth Therapeutics, a biopharma company, is diving into Bitcoin, setting aside up to $1 million to tap into its potential as a hedge against inflation. This decision, backed by Hoth's board, mirrors a growing trend among US businesses post-Trump's reelection, as interest in Bitcoin surges. US Senator Cynthia Lummis has also suggested the Treasury convert some gold reserves to Bitcoin, emphasizing its inflation-resistant nature. Meanwhile, MicroStrategy's Michael Saylor is pitching Bitcoin to Microsoft's board, highlighting the increasing corporate interest in the cryptocurrency as a strategic asset.